期刊文献+

Immunopathobiology and therapeutic targets related to cytokines in liver diseases 被引量:16

原文传递
导出
摘要 Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases cirrhosis and hepatocellular carcinoma.The progression of liver disease is controlled by a variety of factors,including liver injury,inflammatory cells,inflammatory mediators,cytokines,and the gut microbiome.In the current review,we discuss recent data on a large number of cytokines that play important roles in regulating liver injury,inflammation,fibrosis,and regeneration,with a focus on interferons and T helper(Th)1,Th2,Th9,Th17,interleukin(IL)-1 family,IL-6 family,and IL-20 family cytokines.Hepatocytes can also produce certain cytokines(such as IL-7,IL-11;and IL-33),and the functions of these cytokines in the liver are briefly summarized.Several cytokines have great therapeutic potential,and some are currently being tested as therapeutic targets in clinical trials for the treatment of liver diseases,which are also described.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2021年第1期18-37,共20页 中国免疫学杂志(英文版)
基金 supported by the intramural program of the NIAAA(Bin Gao),U01 AA022614,and R01 DK099205(Tatiana Kisseleva)and AA011576 and AA017729(Gyongyi Szabo).
  • 相关文献

参考文献8

二级参考文献20

  • 1Wei Zhang,Bei Yue,Gui-Qiang Wang,Shu-Lan Lu the Department of Infectious Dispeases, Ruijing Hospital, Shanghai Second Medical University, Shanghai 200025, China Department of Intectious Diseases, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China.Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):577-580. 被引量:18
  • 2Sun Z,Klein A,Radaeva S,et al.In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats[].Gastroenterology.2003
  • 3Hong F,Jaruga B,Kim WH,el al.Opposing roles of STATI and STAT3 in T cell-mediated hepatitis:regulation by SOCS[].The Journal of Clinical Investigation.2002
  • 4Galun E,Zeira E,Pappo O,Peters M,Rose-John S.Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury[].The FASEB Journal.2000
  • 5Kammuller ME.Recombinant human interlcukin-6:safety issues of a pleiotropic growth factor[].Toxicology.1995
  • 6Kovalovich K,Li W,DeAngelis R,Greenbaum LE,Ciliberto G,Taub R.Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP,Bc1-2,and Bcl-xL[].Journal of Biological Chemistry.2001
  • 7Selzner M,Camargo CA,Clavien PA.Ischemia impairs liver regeneration after major tissue loss in rodents:protective effects of interleukin-6[].Hepatology.1999
  • 8Kotenko SV,lzotova LS,Mirochnitchenko OV,et al.Identification of the functional interleukin-22(IL-22) receptor complex:the IL-10R2 chain(IL-10Rbeta)is a common chain of both the IL-10 and IL-22(IL-10-related T cell-derived inducible factor,IL-TIF)receptor complexes[].Journal of Biological Chemistry.2001
  • 9Haga S,Terui K,Zhang HQ,et al.Star3 protects against Fas-induced liver injury by redox-dependent and-independent mechanisms[].The Journal of Clinical Investigation.2003
  • 10Fickenscher H,Hor S,Kupers H,Knappe A,Wittmann S,Sticht H.The interleukin-10 family of cytokines[].Trends in Immunology.2002

共引文献102

同被引文献99

引证文献16

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部